DeepMed Research

Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease

Completed

Conditions: Mild Cognitive Impairment

Interventions: Device: PrecivityAD

First Posted Date: 2023-05-06

Last Posted Date: 2023-07-25

Lead Sponsor: Indiana University

Target Recruit Count: 26

Registration Number: NCT05844488

Locations: 🇺🇸
Indiana University Health Physicians Primary Care, Indianapolis, Indiana, United States

Enhancing Prospective Thinking in Early Recovery

Not Applicable

Recruiting

Conditions: Stimulant Use
Substance Use Disorders

Interventions: Device: Virtual Reality

First Posted Date: 2023-04-28

Last Posted Date: 2025-04-01

Lead Sponsor: Indiana University

Target Recruit Count: 88

Registration Number: NCT05835921

Locations: 🇺🇸
Indiana University School of Medicine - Goodman Hall, Indianapolis, Indiana, United States

Developing a Childhood Asthma Risk Passive Digital Marker

Not Applicable

Recruiting

Conditions: Pediatric Asthma

Interventions: Other: Childhood Asthma Passive Digital Marker

First Posted Date: 2023-04-24

Last Posted Date: 2024-07-24

Lead Sponsor: Indiana University

Target Recruit Count: 100

Registration Number: NCT05826561

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Not Applicable

Recruiting

Conditions: Cold Exposure

Interventions: Dietary Supplement: Fish Oil
Dietary Supplement: Placebo

First Posted Date: 2023-04-20

Last Posted Date: 2025-04-07

Lead Sponsor: Indiana University

Target Recruit Count: 30

Registration Number: NCT05822141

Locations: 🇺🇸
Human Perfromance Lab, Indiana University, Bloomington, Indiana, United States

Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen

Phase 4

Recruiting

Conditions: Constipation

Interventions: Drug: PEG 3350
Drug: PEG-3350 with electrolytes
Drug: Glycerin

First Posted Date: 2023-04-20

Last Posted Date: 2024-08-05

Lead Sponsor: Indiana University

Target Recruit Count: 50

Registration Number: NCT05821309

Locations: 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States
🇺🇸
IU North Hospital, Carmel, Indiana, United States

A Nasal Treatment for COVID-19

Phase 2

Recruiting

Conditions: COVID-19

Interventions: Drug: Optate
Drug: Placebo

First Posted Date: 2023-04-05

Last Posted Date: 2025-05-04

Lead Sponsor: Indiana University

Target Recruit Count: 40

Registration Number: NCT05799521

Locations: 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States

Interaction of CYP2B6 Genotype and Efavirenz with Methadone and Tizanidine PK

Early Phase 1

Recruiting

Conditions: Drug-Drug Interaction

Interventions: Drug: Methadone and Tizanidine
Drug: Efavirenz, Methadone and Tizanidine

First Posted Date: 2023-03-29

Last Posted Date: 2025-01-27

Lead Sponsor: Indiana University

Target Recruit Count: 60

Registration Number: NCT05789173

Locations: 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States

Comparison of Tissue Oxygenation Measurement Using Multimodal Devices

Not Applicable

Completed

Conditions: Oxygen Saturation

Interventions: Device: Clarifi Modulum
Device: Perimed PeriFlux 5000
Device: Apple Watch Oxygen Sensor
Device: Innovo iP 900AP

First Posted Date: 2023-03-24

Last Posted Date: 2023-11-29

Lead Sponsor: Indiana University

Target Recruit Count: 20

Registration Number: NCT05784103

Locations: 🇺🇸
Surya C. Gnyawali, University of Pittsburgh, UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸
Indiana University, School of Medicine, Indianapolis, Indiana, United States

Using Circulating Tumor DNA to Personalize Duration of Consolidation Durvalumab

Phase 2

Recruiting

Conditions: NSCLC, Stage III

Interventions: Diagnostic Test: Signatera ctDNA test
Drug: Durvalumab

First Posted Date: 2023-03-07

Last Posted Date: 2024-08-09

Lead Sponsor: Indiana University

Target Recruit Count: 56

Registration Number: NCT05757843

Locations: 🇺🇸
Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States

Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center

Not Applicable

Withdrawn

Conditions: Positive-Pressure Respiration
Colonoscopy

Interventions: Device: Nasal Positive Airway Pressure System
Device: Nasal Cannula

First Posted Date: 2023-03-03

Last Posted Date: 2025-04-04

Lead Sponsor: Indiana University

Registration Number: NCT05754255

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy